Search - tctmd.com

Displaying 401 - 420 of 802

Sort: Relevancy | Date

News Daily News

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Caitlin E. Cox

July 17, 2018

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

L.A. McKeown

July 03, 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Jeffrey J. Popma

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Presenter: Alexander Lauten

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Presenter: Michael J. Mack

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Presenter: Howard C. Herrmann, Fabian Nietlispach, Cenap Undemir, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Industry News

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

April 19, 2018

News Daily News

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

Caitlin E. Cox

April 17, 2018

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Industry News

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

February 26, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Todd Neale

January 17, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

Advertisement

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Evolut R Low-Risk

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

TCTMD’s Top 10 Most Popular Stories for January 2018

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content